Unsere Berater

Name: Shlomo Yanai
Fachgebiet: Healthcare, Industrials, Business Services
Adviser to CVC since 2015. Mr Yanai has been President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd. from 2007 till mid 2012. Prior to joining Teva, Mr. Yanai was the President & CEO of Makhteshim Agan Industries (Agro-chemicals) from 2003 till 2006 where he was also the Chairman of the Board of Makhteshim Chemical Works Ltd., Agan Chemical Manufacturers Ltd, Milenia Agro Chemicals and Aroma Fine Chemicals Ltd. Mr.Yanai is currently the Chairman of the Board of the Cambrex Corporation, chairman of the Board of Protalix Biotherapeutics , Vice Chairman of the Rothschild Caesarea Foundation, Board member at Lumenis, Board member at Sagent Pharmaceuticals and a Board member at Quinpario Acquisition Corp. 2. Mr. Yanai was also a board member of Elisra (high-tech defense electronic devices), Bank Leumi Le-Israel (Israel's second largest bank) and I.T.L. Optronics Ltd. Shlomo Yanai is a graduate of the Harvard Business School's AMP program. Holds a MPA from the George Was